This company seems to have been delisted
Reason: Filed for bankruptcy
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/biolase-voluntarily-initiates-chapter-11-proceedings-926432
Reason: Filed for bankruptcy
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/biolase-voluntarily-initiates-chapter-11-proceedings-926432
Biolase
BIOL
₹1.03
Share price
0.00%
Change (1 day)
-92.74%
Change (1 year)
Categories
Biolase (BIOL) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : ₹2.78 Billion
According to Biolase 's latest financial reports the company's total liabilities are ₹2.78 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Biolase - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | ₹2.75 B | 23.08% |
| 2021-12-31 | ₹2.23 B | -1.25% |
| 2020-12-31 | ₹2.26 B | 1.01% |
| 2019-12-31 | ₹2.24 B | 17.02% |
| 2018-12-31 | ₹1.91 B | 118.85% |
| 2017-12-31 | ₹0.87 B | -35.12% |
| 2016-12-31 | ₹1.35 B | 17.31% |
| 2015-12-31 | ₹1.15 B | 4.73% |
| 2014-12-31 | ₹1.09 B | -21.11% |
| 2013-12-31 | ₹1.39 B | 26.13% |
| 2012-12-31 | ₹1.10 B | 21.16% |
| 2011-12-31 | ₹0.91 B | -3.98% |
| 2010-12-31 | ₹0.94 B | 43.65% |
| 2009-12-31 | ₹0.66 B | -47.74% |
| 2008-12-31 | ₹1.26 B | 15.87% |
| 2007-12-31 | ₹1.09 B | -7.38% |
| 2006-12-31 | ₹1.17 B | 9.89% |
| 2005-12-31 | ₹1.07 B | -0.01% |
| 2004-12-31 | ₹1.07 B | 75.84% |
| 2003-12-31 | ₹0.61 B | -1.25% |
| 2002-12-31 | ₹0.61 B | 114.02% |
| 2001-12-31 | ₹0.28 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Align Technology
ALGN | ₹198.30 B | 7,010.32% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | ₹347.03 B | 12,343.02% | 🇺🇸 USA |